Vident Investment Advisory, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$58,935
-41.8%
33,486
+3.9%
0.00%
-50.0%
Q4 2022$101,243
-16.3%
32,243
+30.6%
0.00%0.0%
Q3 2022$121,000
+31.5%
24,681
+11.1%
0.00%
+33.3%
Q2 2022$92,000
-10.7%
22,210
+24.7%
0.00%0.0%
Q1 2022$103,000
-36.0%
17,814
-17.0%
0.00%
-25.0%
Q4 2021$161,000
-26.1%
21,454
+18.1%
0.00%
-42.9%
Q2 2021$218,00018,1720.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders